{"code":"HSC","codeName":"Health and Safety Code","section":"125290.71","citation":"Health & Saf. Code, § 125290.71","status":"in-force","lawOn":"2026-09-28","headings":[{"name":"DIVISION 106. PERSONAL HEALTH CARE (INCLUDING MATERNAL, CHILD, AND ADOLESCENT) [123100. - 125850.]","url":"https://blackletter.si/health-and-safety-code/division-106"},{"name":"PART 5. HEREDITARY DISEASES/CONGENITAL DEFECTS [124975. - 125292.10.]","url":"https://blackletter.si/health-and-safety-code/division-106/part-5"},{"name":"CHAPTER 3. California Stem Cell Research and Cures Bond Act [125290.10. - 125292.10.]","url":"https://blackletter.si/health-and-safety-code/division-106/part-5/chapter-3"},{"name":"ARTICLE 1. California Stem Cell Research and Cures Act [125290.10. - 125290.80.]","url":"https://blackletter.si/health-and-safety-code/division-106/part-5/chapter-3/article-1"}],"history":"Added by Stats. 2010, Ch. 637, Sec. 7.   (SB 1064)   Effective January 1, 2011.","effective":"2011-01-01","html":"<p>Under the guidance of the ICOC, the institute shall, by January 31, 2012, create a transition plan addressing the expiration of current bond funding. A copy of the transition plan shall be transmitted to the Governor, the Controller, and the Legislature within 30 days of its completion.</p>","text":"Under the guidance of the ICOC, the institute shall, by January 31, 2012, create a transition plan addressing the expiration of current bond funding. A copy of the transition plan shall be transmitted to the Governor, the Controller, and the Legislature within 30 days of its completion.","otherVersions":[],"url":"https://blackletter.si/health-and-safety-code/california-stem-cell-research-and-cures-act-125290-71","source":"California Legislative Information bulk export (pubinfo)"}